Abstract
Background
Loss of muscle mass and muscle weakness are often found in cases of acute or chronic illness in elderly patients. Sarcopenia is a risk factor for complications and higher mortality. Based on an exact diagnosis and knowledge of the risk factors for developing sarcopenia, it is now possible to improve the prognosis by providing effective treatment options.
Methods
This review was carried out based on a PubMed search in the period from 1998 to 2015 using original articles and reviews and posting the terms “sarcopenia”, “elderly” and “acute illness”.
Conclusion
Given the evidence from the current literature, in the case of acute illness it is feasible to identify patients at risk, diagnose sarcopenia and prescribe a multidimensional treatment program to prevent or treat sarcopenia even in the bustling environment of geriatric wards or institutions.
Zusammenfassung
Hintergrund
Muskelschwund und Muskelschwäche sind häufige Begleiter einer akuten oder chronischen Erkrankung im Alter. Sarkopenie ist ein Risikofaktor für erhöhte Komplikationsraten und erhöhter Mortalität. Auf einer exakten Diagnose und des Wissens über die Risikofaktoren für die Entwicklung einer Sarkopenie ist es heute möglich, effektive Behandlungsmethoden anzuwenden, um die Prognose zu verbessern.
Methode
Es erfolgte eine Pub Med-Literaturrecherche von Originalarbeiten und Übersichtsarbeiten in der Periode von 1998 bis 2015, basierend auf der Verwendung der Begriffe “Sarkopenie”, “akute Erkrankung” und “Ältere”.
Schlussfolgerung
Gemäß der aktuellen Literatur ist es möglich, auch in der geschäftigen Umgebung von medizinischen Einrichtungen für Ältere, im Falle einer akuten Erkrankung das Risiko für eine Sarkopenie zu erkennen, exakt zu diagnostizieren und umfassend zu behandeln.
Similar content being viewed by others
References
Barnes DE, Palmer RM, Kresevic DM, Fortinsky RH, Kowal J, Chren M-M, Landefeld CS (2012) Acute care for elders units produced shorter hospital stays at lower cost while maintaining patients’ functional status. Health Aff 31:1227–1236
Basualto-Alarcón C, Varela D, Duran J, Maass R, Estrada M (2014) Sarcopenia and Androgens: a link between pathology and treatment. Front Endocrinol (Lausanne) 5:217
Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14:542–559
Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, McMurdo ME, Mets T, Seal C, Wijers SL, Ceda GP, De Vito G, Donders G, Drey M, Greig C, Holmbäck U, Narici M, McPhee J, Poggiogalle E, Power D, Scafoglieri A, Schultz R, Sieber CC, Cederholm T (2015) Effects of a vitamin d and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 16:740–747
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763
Baztan JJ, Suarez-Garcia FM, Lopez-Arrieta J, Rodriguez-Manas L, Rodriguez-Artalejo F (2009) Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: meta-analysis. BMJ 338:b50–b50
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692–b3692
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of Vitamin D on falls: a meta-analysis. JAMA 291:1999–2006
Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlögl M, Staehelin HB, Willett WC, Dawson-Hughes B (2015) Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. doi:10.1007/s00198-015-3194-y
van de Bool C, Rutten EP, Franssen FM, Wouters EF, Schols AM (2015) Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur Respir J 46:336–345
Candow DG, Little JP, Chilibeck PD, Abeysekara S, Zello GA, Kazachkov M, Cornish SM, Yu PH (2008) Low-dose creatine combined with protein during resistance training in older men. Med Sci Sports Exerc 40:1645–1652
Cesari M, Kritchevsky SB, Newman AB, Simonsick EM, Harris TB, Penninx BW, Brach JS, Tylavsky FA, Satterfield S, Bauer DC, Rubin SM, Visser M, Pahor M, Health AiaBCS (2009) Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 57:251–259
Chien MY, Huang TY, Wu YT (2008) Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 56:1710–1715
Cooper C, Burden ST, Cheng H, Molassiotis A (2015) Understanding and managing cancer-related weight loss and anorexia: insights from a systematic review of qualitative research. J Cachexia Sarcopenia Muscle 6:99–111
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older P (2010) Sarcopenia: european consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423
Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759
Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH, Health, Aging, and Body (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90:1579–1585
Doherty TJ (2003) Invited review: aging and sarcopenia. J Appl Physiol (1985) 95:1717–1727
Dovjak P (2012) Tools in polypharmacy. Current evidence from observational and controlled studies. Z Gerontol Geriatr 45:468–472
Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG, Group ACaESA (2014) Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 156:521–527
Ellis G, Whitehead MA, O’Neill D, Langhorne P, Robinson D (2011) Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev 7:CD006211
Ellis G, Whitehead MA, Robinson D, O’Neill D, Langhorne P (2011) Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 343:d6553–d6553
Extermann M (2012) Integrating a geriatric evaluation in the clinical setting. Semin Radiat Oncol 22:272–276
Fiatarone MA, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ (1994) Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330:1769–1775
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256
Fox MT, Persaud M, Maimets I, O’Brien K, Brooks D, Tregunno D, Schraa E (2012) Effectiveness of acute geriatric unit care using acute care for elders components: a systematic review and meta-analysis. J Am Geriatr Soc 60:2237–2245
Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R (2000) Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol (1985) 88:1321–1326
Gaddey HL, Holder K (2014) Unintentional weight loss in older adults. Am Fam Physician 89:718–722
Garfinkel D, Mangin D (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 170:1648–1654
van Iersel MB, Olde Rikkert MG (2010) Sudden decline in mobility as an indicator of infection and disclosure of subclinical sarcopenia: four cases. J Am Geriatr Soc 58:1395–1396
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52:80–85
Jeon YK, Shin MJ, Kim MH, Mok JH, Kim SS, Kim BH, Kim SJ, Kim YK, Chang JH, Shin YB, Kim IJ (2015) Low pulmonary function is related with a high risk of sarcopenia in community-dwelling older adults: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008–2011. Osteoporos Int 26:2423–2429
Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, Malani PN (2013) Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 19:1396–1402
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42:203–209
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 95:1851–1860
Laviano A, Inui A, Marks DL, Meguid MM, Pichard C, Rossi Fanelli F, Seelaender M (2008) Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab 295:E1000–E1008
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61–65
Marzetti E, Calvani R, Bernabei R, Leeuwenburgh C (2012) Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty—a mini-review. Gerontology 58:99–106
Masuko K (2014) Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr 1:20
McCusker J, Bellavance F, Cardin S, Trépanier S, Verdon J, Ardman O (1999) Detection of older people at increased risk of adverse health outcomes after an emergency visit: the ISAR screening tool. J Am Geriatr Soc 47:1229–1237
Meriggioli MN, Roubenoff R (2015) Prospect for pharmacological therapies to treat skeletal muscle dysfunction. Calcif Tissue Int 96:234–242
Miller MS, Callahan DM, Toth MJ (2014) Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans. Front Physiol 5:369
Moreland JD, Richardson JA, Goldsmith CH, Clase CM (2004) Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 52:1121–1129
Morley JE (2015) Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int
Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD, Society on Sarcopenia CcaWDTW (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409
Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Rossi Fanelli F, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) „cachexia-anorexia in chronic wasting diseases“ and „nutrition in geriatrics“. Clin Nutr 29:154–159
Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, Amodeo C, Cuppari L, Kamimura MA (2015) Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30(10):1718–1725
Revenig LM, Canter DJ, Taylor MD, Tai C, Sweeney JF, Sarmiento JM, Kooby DA, Maithel SK, Master VA, Ogan K (2013) Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg 217(665–670):e661
Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D, Vellas B, Grandjean H (2003) Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc 51:1120–1124
Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S–991S
Seematter-Bagnoud L, Monod S, Büla C, Rège-Walther M, Peytremann-Bridevaux I (2013) Verbessern umfassende geriatrische Assessments die Betreuung älterer Menschen nach einem Spitalaufenthalt? Praxis 102:167–168
Sieber CC (2007) [Malnutrition in the elderly–when too much turns into too few]. Z Gerontol Geriatr 40:1–2
Sommeregger U (2013) [The multidimensional geriatric assessment]. Z Gerontol Geriatr 46:277–285. quiz 285–276
Sommeregger U, Rosenberger-Spitzy A, Gatterer G, Baumgartner E, Meisl E, Popp W (1997) [Geriatric assessment–the Vienna model]. Z Gerontol Geriatr 30:235–241
Souza VA, Oliveira D, Mansur HN, Fernandes NM, Bastos MG (2015) Sarcopenia in chronic kidney disease. J Bras Nefrol 37:98–105
Springer J, Schust S, Peske K, Tschirner A, Rex A, Engel O, Scherbakov N, Meisel A, von Haehling S, Boschmann M, Anker SD, Dirnagl U, Doehner W (2014) Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia. Stroke 45:3675–3683
Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J (2011) Gait speed and survival in older adults. JAMA 305:50–58
Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM (2015) Managing patients with multimorbidity in primary care. BMJ 350:h176
Yoshida T, Delafontaine P (2015) Mechanisms of cachexia in chronic disease states. Am J Med Sci 350:250–256
Zamboni M, Rossi AP, Corzato F, Bambace C, Mazzali G, Fantin F (2013) Sarcopenia, cachexia and congestive heart failure in the elderly. Endocr Metab Immune Disord Drug Targets 13:58–67
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
P. Dovjak states that there are no conflicts of interest.
This article does not contain any studies with human or animal subjects.
Rights and permissions
About this article
Cite this article
Dovjak, P. Sarcopenia in cases of chronic and acute illness. Z Gerontol Geriat 49, 100–106 (2016). https://doi.org/10.1007/s00391-015-0986-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00391-015-0986-9